Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ra Capital Management, L.P. sold 128,770 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $0.39, for a total transaction of $50,220.30. Following the completion of the sale, the insider owned 341,353 shares […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ra Capital Management, L.P. sold 170,441 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $0.40, for a total transaction of $68,176.40. Following the transaction, the insider directly owned 349,907 shares […]

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) Director Ra Capital Management, L.P. bought 124,893 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The shares were purchased at an average cost of $8.89 per share, with a total value of $1,110,298.77. Following the transaction, the director directly owned 16,763,043 […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ra Capital Management, L.P. sold 262,503 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $0.38, for a total value of $99,751.14. Following the transaction, the insider owned 361,229 shares in […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ra Capital Management, L.P. sold 45,923 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $0.37, for a total transaction of $16,991.51. Following the completion of the sale, the insider directly owned 378,666 […]

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) Director Ra Capital Management, L.P. acquired 479,039 shares of the company’s stock in a transaction on Tuesday, June 9th. The shares were purchased at an average cost of $6.91 per share, with a total value of $3,310,159.49. Following the completion of the acquisition, the director directly owned […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 76,928 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $0.37, for a total transaction of $28,463.36. Following the transaction, the director directly owned 300,283 shares of the company’s stock, valued at […]

Abeona Therapeutics Inc. (NASDAQ:ABEO – Get Free Report) SVP Brendan O’malley sold 6,305 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $5.30, for a total value of $33,416.50. Following the sale, the senior vice president directly owned 440,003 shares of the company’s […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 29,749 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $0.42, for a total transaction of $12,494.58. Following the transaction, the director owned 482,776 shares of the company’s stock, valued at […]